In contrast to the already published preclinical studies, which have focused on PD-L1 imaging of subcutaneous tumours, we aimed to investigate whether ZPD-L1-based radioconjugates have the capacity to visualise PD-L1-positive cells in brain tumours. Here, CD274 is linked to neoplasm.